Erythromycin
Ethylsuccinate (E.E.S., EryPed)
|
Category:
Description:
Indications:
-
Upper
respiratory tract infections (S.
pyogenes, S. pneumoniae, H. inlfuenzae)
-
Lower
respiratory tract infections (S.
pyogenes, S. pneumoniae)
-
Respiratory
tract infections (Mycoplasma
pneumoniae)
-
Skin
infections (S. aureus, S.
pyogenes)
-
Pertussis
(Bordetella pertussis)
-
Diphtheria
(Corynebacterium diphtheriae)
-
Erythasma
(C. minutissimum)
-
Intestinal
amebiasis (Entamoeba histolytica)
-
Pelvic
inflammatory disease (N.
gonorrhoeae)
-
Conjunctivitis
(Chlamydia trachomatis)
-
Uncomplicated
urethral, endocervical or rectal infections (Chlamydia
trachomatis)
-
Nongonococcal
urethritis (Ureaplasma
urealyticum)
-
Primary
syphilis (Treponema pallidum)
-
Legionnaire’s
disease (Legionella pneumonphila)
-
Rheumatic
fever
-
Bacterial
endocarditis
-
Listeria monocytogenes infections
-
Unlabled
uses: Treponema pallidum,
Campylobacter jejuni, Lymphogranuloma vernereum, Calymmatobacterium
granulomatis, Haemophilus ducreyi (chanchroid)
Contraindications:
Precautions:
-
Pregnancy
category B
-
Counsel
patient to finish all medication to prevent development of resistance
-
Do
not use with cisapride (ventricular arrythmias w/macrolides)
-
Optimal
serum levels are achieved if taken in fasting state or immediately
before meals (base and stearate formulations).
Ehtylsuccinate,estolate and enteric-coated erythromycin
formulations may be administered without regard for meals.
-
Urine
alkalinization (pH 8.5) increases gram-negative antibacterial
activity. If needed, administer with sodium bicarbonate or other
alkalinizing agent
-
Dosages
are expressed in the form of erythromycin base:
-
Erythromycin
Ethylsuccinate 400mg = 250mg of erythromycin base
Adverse
Reactions (Side Effects):
-
Hypersensitivity
-
Gastrointestinal:
abdominal pain (7.5%), nausea, vomiting, diarrhea (7.3%)
-
Headache
(8.2%)
-
Decreased
platelet count (4.8%)
-
Vaginitis
|
Dosage:
|
Source:
Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington,
D.C., 20372-5300
|